Calibr at Scripps Research
Sean Joseph has extensive work experience in the pharmaceutical and biotechnology industry. Sean started their career as a Postdoctoral fellow at the Howard Hughes Medical Institute in 2002. Sean then joined Pfizer as a Senior Scientist in 2003 and worked there until 2005. Sean then joined the Genomics Institute of the Novartis Research Foundation as a Senior Research Investigator I, where they worked for eight years. In 2013, they joined Genentech as a Senior Scientist / Group Leader and stayed with the company until 2016. Currently, they are working at Calibr at Scripps Research, where they started as a Director of Pharmacology in 2016 and was promoted to VP of Nonclinical Development in 2019.
Sean Joseph earned a B.S. in Biochemistry and Cell Biology from UC San Diego between 1992 and 1996. After that, they pursued a Ph.D. in Cellular and Molecular Pathology at UCLA from 1996 to 2002.
Calibr at Scripps Research
1 followers
The California Institute for Biomedical Research (Calibr) is a first-of-its-kind, nonprofit translational research institute dedicated to accelerating the next generation of medicines. Affiliated with Scripps Research—among the most innovative institutes worldwide—we spearhead drug discovery from a steady flow of pioneering science. Our self-sustaining model encourages broad and bold exploration with far-reaching goals, yet rapid transition of our most successful, high-impact programs into the clinic. We pursue audacious and imaginative ideas—bridging scientific and technological advances to develop new medicines for unmet medical needs. Our pipeline programs range from cancer to infectious diseases and from discovery to early clinical trial stages, all aimed at preventing disease and healing humans around the world. We bring together leaders in research, drug development, and business to answer important biological questions and develop new interventions to treat, cure, and prevent disease. Our infrastructure and expertise extend from high-throughput screening and protein engineering to pharmacology and clinical development. Calibr’s research space includes a newly renovated 35,000 square foot facility in La Jolla, CA, which houses over 100 interdisciplinary scientists and staff with state-of-the-art instrumentation. This infrastructure, combined with Calibr’s drug discovery expertise, enables projects rooted in novel therapeutic mechanisms to progress from the laboratory through preclinical development and ultimately to the clinic through commercial, federal, or foundation partnerships.